Retrospective cohort study for assessment of association between imaging changes and outcome after treatment of regorafenib(KSCC1603)
Not Applicable
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000023329
- Lead Sponsor
- Kyushu Study group of Clinical Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with active double cancer. Carcinoma in situ (intraepithelial carcinoma) or the intramucosal carcinoma equivalent lesion which are concurrent double cancers and heterochronous double cancers within five years of progression free, and the investigator judged to cure by topical treatment, are excluded as the double cancer. 2. Any other patients who are regarded as unsuitable for this study by the investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method